Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00940888 · ClinicalTrials.gov registry record
SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients
A clinical trial of Heart Failure and Sudden Cardiac Death, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 1,701
- Enrollment target
- 1
- Study location
NCT00940888 is a study of Heart Failure and Sudden Cardiac Death that has completed, run by Abbott Medical Devices. The registered enrollment target is 1,701 participants, below the 2,045-participant average among 397 other Heart Failure trials with a reported enrollment target (17% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00940888, a study of Heart Failure and Sudden Cardiac Death, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 1,701 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to characterize the chronic performance of the St. Jude Medical SJ4 connector and RV high voltage SJ4 leads.
Conditions Studied
Interventions
- DEVICE SJ4 connector and RV high voltage SJ4 lead
Study Locations (1)
Ohio
- The Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,701 participants |
| Start Date | 2009-06 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00940888
The ClinicalTrials.gov registry entry for NCT00940888 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,701 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,045-participant average among 397 other Heart Failure trials with a reported enrollment target (17% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which SJ4 connector and RV high voltage SJ4 lead is the first listed.
NCT00940888 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT00940888 about?
NCT00940888 is a clinical study titled "SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients". The purpose of this study is to characterize the chronic performance of the St. Jude Medical SJ4 connector and RV high voltage SJ4 leads.
What is the current status of trial NCT00940888?
This trial is currently completed. The enrollment target is 1,701 participants. The study started on 2009-06. Estimated completion is 2015-12.
What conditions does trial NCT00940888 study?
This clinical trial studies the following conditions: Heart Failure, Sudden Cardiac Death, Tachyarrhythmias.
What interventions are being tested in trial NCT00940888?
The interventions under investigation include: SJ4 connector and RV high voltage SJ4 lead (DEVICE).
Who is sponsoring clinical trial NCT00940888?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00940888 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.